Peter F Zipfel

Peter F Zipfel is a Professor and Head of the Department of Infection Biology at the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute in Jena, Germany. He has held this leadership position since January 2012 while also serving as Managing Director of the Infection Biology department. Previously, he was affiliated with Universitätsklinikum Jena from 2009 to 2011. His academic profile reflects deep expertise at the intersection of immunology, infection biology, and clinical medicine, with particular focus on the complement system's role in health and disease.

Dr. Zipfel's research program centers on the complement system and its critical functions in human immunity. His work explores molecular mechanisms of complement regulation through proteins like Factor H and Factor H-related proteins, and how pathogens such as Staphylococcus aureus, Candida albicans, and Aspergillus fumigatus evade complement-mediated destruction. He has made seminal contributions to understanding complement-mediated kidney diseases including C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS), as well as the role of complement in age-related macular degeneration. His laboratory investigates how genetic variations in complement regulators influence disease susceptibility and progression.

Analysis of Dr. Zipfel's extensive publication record (over 737 publications) reveals a consistent trajectory from fundamental molecular studies to clinical applications. His recent work shows increasing focus on translational research, particularly the development of recombinant complement proteins as therapeutics, including moss-produced Factor H variants with enhanced properties. His research bridges basic immunology with clinical nephrology, ophthalmology, and infectious disease, addressing critical gaps in understanding and treatment of complement-related disorders across multiple organ systems.

Dr. Zipfel leads an active research laboratory at the Hans Knöll Institute with numerous national and international collaborations. His work has generated over 77,500 publication reads and 31,643 citations, demonstrating significant impact in the field. While specific grant details aren't provided in the available information, his sustained research output suggests continuous funding supporting investigations into complement biology, pathogen evasion strategies, and therapeutic interventions for complement-mediated diseases.

Dr. Zipfel's laboratory focuses on molecular mechanisms of host-pathogen interactions with particular attention to complement system evasion by microbial pathogens. His team employs multidisciplinary approaches spanning structural biology, molecular techniques, and clinical studies to investigate how pathogens manipulate human immune responses and how complement dysregulation leads to diverse pathologies. This research has important implications for developing novel diagnostic tools and therapeutic strategies for complement-mediated disorders worldwide.